CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid in Capital	Accumulated Other Comprehensive Income/(Loss)	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024		33,893,409
Beginning balance at Dec. 31, 2024	$ 2,503,405	$ 34	$ 12,305,250	$ 1,451	$ (9,803,330)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(106,213)				(106,213)
Stock-based compensation expense	16,261		16,261
Other comprehensive (loss) income	215			215
Release of restricted stock units (in shares)		1,403,449
Release of restricted stock units	0	$ 1	(1)
Ending balance (in shares) at Mar. 31, 2025		35,296,858
Ending balance at Mar. 31, 2025	$ 2,413,668	$ 35	12,321,510	1,666	(9,909,543)
Beginning balance (in shares) at Dec. 31, 2025	40,331,360	40,331,360
Beginning balance at Dec. 31, 2025	$ 2,577,862	$ 40	12,786,848	2,655	(10,211,681)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(93,187)				(93,187)
Stock-based compensation expense	16,793		16,793
Other comprehensive (loss) income	(782)			(782)
Release of restricted stock units (in shares)		802,859
Release of restricted stock units	$ 0	$ 1	(1)
Ending balance (in shares) at Mar. 31, 2026	41,134,219	41,134,219
Ending balance at Mar. 31, 2026	$ 2,500,686	$ 41	$ 12,803,640	$ 1,873	$ (10,304,868)